加利福尼亚州，山景城 -（2015 年 10 月 27 日）- 提供全球顶级大学公开课程的最大规
模平台 , Coursera宣布近期开展的 C 轮融资活动获得新加坡经济发展局的专业企业投资
机构 EDBI 投资参与。

SUNNYVALE, Calif., Oct. 26, 2015 /PRNewswire/ — Enlighted Inc., a leading provider of Internet
of Things (IoT) solutions for commercial buildings, has announced the launch of two web
applications: Enlighted Aire,a tool that provides demand-driven heating and / or cooling control,
and Enlighted Space, a tool that provides rich visualization and reporting of building utilization.

IRVINE, Calif., Oct. 22, 2015 /PRNewswire/ — Greenwave
Systems®(www.greenwavesystems.com), the global Internet of Things (IoT)
software and managed services leader, received the “Most Innovative Internet
of Things Solution” award at Broadband World Forum. Regarded as the most
prestigious recognition of excellence in the broadband marketplace, the award
ceremony took place on October 21st in London.

SAN FRANCISCO, Oct. 21, 2015 /PRNewswire/ — DocuSign, Inc. (DocuSign®) announced a list
of top business and industry leaders who have joined The DocuSign Global Trust Network as
individual investors

SAN DIEGO, Oct 21, 2015 (BUSINESS WIRE) — PatientSafe Solutions, a leader in
connected workflow and care coordination solutions for healthcare, today announced it has
acquired all assets of Vree Health, a wholly owned subsidiary of Merck and a provider of
service-enabled care coordination technology designed to influence positive behavioral
change and enhance the patient experience.

LOWELL, Mass., Oct. 19, 2015 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, the
provider of automated, rapid, non-destructive detection and enumeration technologies in
microbiology, today announced the launch of the sterility testing application for the Growth
Direct™ System.

SAN FRANCISCO, Oct. 16, 2015 /PRNewswire/ — Lithium is the proud recipient of this year’s
WebAward for Best Computer: Software Website for lithium.com.

MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) — Amaranth Medical, a
privately held medical device company, announced that enrollment has successfully
concluded in its multi-center, international CE Mark clinical trials: MEND-II and
RENASCENT-I, which assessed Amaranth’s FORTITUDE®
sirolimus-eluting bioresorbable
scaffold (BRS) in patients with symptomatic coronary artery disease. All patients have
entered the nine-month follow-up period, which is expected to conclude by mid-2016.

SINGAPORE, 30 September 2015 – QT Vascular Ltd., together with its subsidiaries (the
“Company” or “QT Vascular”, and together with its subsidiaries, the “Group”), a global company
engaged in the design, assembly and distribution of advanced therapeutic solutions for the
minimally invasive treatment of vascular disease, is pleased to announce that, following a sevenday jury trial before an Oakland jury sitting in the United States District Court for the Northern
District of California, it has prevailed on the Patent lawsuit filed by AngioScore (now owned by
Spectranetics Corporation (NASDAQ: SPNC)) (“Plaintiff”) in 2012.